Bromide

Bromide

SCHEMBL7634854

C=Cc1ccc(C[P+](CCCC)(CCCC)CCCC)cc1.[Br-]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 10/20 0.61
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
ALDH1A1 P00352 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CCR5 P51681 1/20 0.37
DNM1 Q05193 2/20 0.36
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
SPHK1 Q9NYA1 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30120525 0.98 BDKRB2 (0.62) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
Iodide SCHEMBL7630309 0.97 BDKRB2 (0.61) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
Hydrochloric Acid SCHEMBL548534 0.97 BDKRB2 (0.66) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
Bromide SCHEMBL7627895 0.93 BDKRB2 (0.65) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
Bromide SCHEMBL7635711 0.93 BDKRB2 (0.65) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
SCHEMBL27200564 0.92 BDKRB2 (0.56) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
SCHEMBL30901612 0.92 BDKRB2 (0.62) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
Hydrochloric Acid SCHEMBL2208229 0.90 BDKRB2 (0.65) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
Iodide SCHEMBL7630057 0.90 BDKRB2 (0.60) BDKRB2TAS1R3TAS1R1ALDH1A1CA1
Hydrochloric Acid SCHEMBL6389237 0.90 BDKRB2 (0.65) BDKRB2TAS1R3TAS1R1ALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945141-B1 Use of a liquid for disinfecting contact lenses MENICON CO LTD (JP) 2002-07-24 EP disclosed
US-20010055603-A1 WATER-SOLUBLE ANTIBACTERIAL POLYMER AND LIQUID FORMULATION COMPRISING IT FOR CONTACT LENSES MENICON CO., LTD. (JP) 2001-12-27 US disclosed
US-20010016190-A1 Water -soluble antibacterial polymer and liquid formulation comprising it for contact lenses MENICON CO., LTD. (JP) 2001-08-23 US disclosed
US-6160069-A Liquid for contact lenses MENICON, CO., LTD. (JP) 2000-12-12 US disclosed
EP-0947856-A2 Ocular lens material Menicon Co., Ltd. (JP) 1999-10-06 EP disclosed
EP-0945141-A2 Liquid for contact lenses Menicon Co., Ltd. (JP) 1999-09-29 EP disclosed
EP-0916682-A1 Water-soluble antibacterial polymer and liquid formulation comprising it for contact lenses Menicon Co., Ltd. (JP) 1999-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010016190-A1 Water -soluble antibacterial polymer and liquid formulation comprising it for contact lenses ARGLU1, H1-0, H1-2 BDKRB2 4844/4885TAS1R3 593/4885TAS1R1 189/4885
US-20010055603-A1 WATER-SOLUBLE ANTIBACTERIAL POLYMER AND LIQUID FORMULATION COMPRISING IT FOR CONTACT LENSES ARGLU1, H1-0, H1-2 BDKRB2 4844/4885TAS1R3 593/4885TAS1R1 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.